Isolated clinic hypertension and normotension: False positives and false negatives in the assessment of hypertension

Blood Pressure Monitoring

Volumn 3, Issue 4, 1998, Pages 247-254

  Larkin, Kevin T ^a   Schauss, Scott L ^a   Elnicki, D Michael ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Ambulatory monitoring of blood pressure; Assessment of blood pressure; Blood pressure measurement standards; Home blood pressure monitoring; Isolated clinic hypertension; Isolated clinic normotension; White coat hypertension

Indexed keywords

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLASSIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOME; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SLEEP TIME; WHITE COAT HYPERTENSION;

EID: 0031774661     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lemne C, Lindvall K, Georgiades A, Fredrikson M, de Faire U. Structural cardiac changes in relation to 24-h ambulatory blood pressure levels in borderline hypertension. J Intern Med 1995; 238:49-57.
2. White WB. Predicting hypertensive heart disease via noninvasive methodology: relationship between ambulatory blood pressure and cardiac indices derived by echocardiography and radionuclide ventriculography. J Hypertens 1990; 8 (suppl 6):S113-S118.
3. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5:93-98.
4. Lin JM, Hsu KL, Chiang FT, Tseng CD, Tseng YZ. Influence of isolated diastolic hypertension identified by ambulatory blood pressure on target organ damage. Int J Cardiol 1995; 48:311-316.
5. Ferrara LA, Guida L, Pansanisi F, Celentano A, Palmieri V, Iannuzzi R, et al. Isolated office hypertension and end-organ damage. J Hypertens 1997; 15:979-985.
6. Mancia G, Zanchetti A, Agebiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
7. Cavillini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
8. Piedomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
9. Hoegholm A, Bang LE, Kristensen KS, Nielson JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 1994; 24:101-105.
10. Larkin KT, Schauss SL, Elnicki DM, Allard H, Robyn S. Is there such a thing as white coat normotension? [abstract]. Psychsom Med 1996; 58:61.
11. Perloff D, Sokolow M. Ambulatory blood pressure: the San Francisco experience. J Hypertens 1990; 8 (suppl 6):S105-S111.
12. Christen Y, Ganslmayer M, Waeber B, Burnier M, Nussberger J, Brunner HR. Use of non-invasive ambulatory blood pressure monitoring to screen for high-risk hypertensive patients. J Hypertens 1990; 8 (suppl 6): S119-S124.
13. Pearce KA, Grimm RH, Rao S, Svendson K, Liebson PR, Neaton JD, et al. Population-derived comparisons of ambulatory and office blood pressures: implications for the determination of usual blood pressure and the concept of white coat hypertension. Arch Intern Med 1992; 152:750-756.
14. Lurbe E, Redon J, Liao Y, Tacons J, Cooper RS, Alvarez V. Ambulatory blood pressure monitoring in normotensive children. J Hypertens 1994; 12:1417-1423.
15. Pickering TG, Harshfield GA, Kleinert HD, Laragh JH. Ambulatory monitoring in the evaluation of blood pressure in patients with borderline hypertension and the role of the defense reflex. Clin Exp Hypertens [A] 1982; 4:675-693.
16. Elijovich F, Laffer CL. Bayesian analysis supports use of ambulatory blood pressure monitors for screening. Hypertension 1992; 19 (suppl 2): II268-II272.
17. The national high blood pressure education program coordinating committee. National high blood pressure education program working group report on ambulatory blood pressure monitoring. Arch Intern Med 1990; 150:2270-2280.
18. Prattichizzo FA, Galetta F. White-coat normotension and blood pressure variability. Angiology 1996, 47:663-668.
19. Musso NR, Giacche M, Galbariggi G, Vergassola C. Blood pressure evaluation by noninvasive and traditional methods. Consistencies and discrepancies among photoplethysmomanometry, office sphygmomanometry, and ambulatory monitoring. Effects of blood pressure measurement. J Hypertens 1996; 9:293-299.
20. Prattichizzo FA, Galetta F. White coat effect on blood pressure. Minerva Cardioangiol 1996; 44:539-543.
21. National high blood pressure education program coordinating committee. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Washington: National Institutes of Health; 1997.
22. White WB, Lund-Johansen P, McCabe EJ. Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. J Hypertens 1989; 7:477-483.
23. White WB, Lund-Johansen P, Omvik P. Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 1990; 65:60-66.
24. Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993; 118:867-882.
25. Staessen JA, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A. Reference values for ambulatory blood pressure: a meta analysis. J Hypertens 1990; 8 (suppl):S57-S64.
26. Multiple Risk Factor Intervention Trial research group. Mortality after 101/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990; 82:1616-1628.